Author: Customer Service

The next-generation CGM is now available in Sweden, with launches expected in Germany, Spain and Italy during the coming weeks as part of a phased roll out Eversense 365 doubles sensor lifespan from the previously available Eversense E3, extending the unique features and benefits of long-term implantable CGM use from six months to a full year GERMANTOWN, Md., April 24, 2026 (GLOBE NEWSWIRE) — Senseonics Holdings, Inc. (NASDAQ: SENS) a medical technology company focused on the development, manufacturing and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced the first European launch of the Eversense® 365 CGM system, the world’s first and only One Year CGM. Following CE Mark approval in January, Eversense 365 is now available to the first patients in...

TORONTO and NEW YORK, April 24, 2026 (GLOBE NEWSWIRE) — illumin Holdings Inc. (TSX: ILLM, OTCQB: ILLMF) (“illumin” or “Company”), a leader in digital advertising technology that empowers marketers to make smarter decisions about communicating with online consumers, will report its first quarter 2026 financial results before market open on Friday, May 8, 2026. Investors and analysts are invited to join a live webcast on Friday, May 8, 2026, at 8:30 AM ET, where CEO Tal Hayek and Interim CFO Michael Amaro will discuss illumin’s first quarter 2026 results, followed by a question-and-answer session. Conference Call Details: To register for the conference call webcast and presentation, please visit: https://events.illumin.com/q1-2026-earnings-call Please connect at least 15 minutes prior, to ensure time for any software download that...

SHANGHAI, China, April 24, 2026 (GLOBE NEWSWIRE) — Hesai Group (“Hesai” or the “Company”) (NASDAQ: HSAI; HKEX: 2525), a global leader in intelligent technology and 3D perception, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the Securities and Exchange Commission (the “SEC”) on April 24, 2026. The annual report, which contains the Company’s audited consolidate statements, can be accessed on the SEC’s website at https://www.sec.gov and on Hesai’s investor relations website at https://investor.hesaitech.com. The Company will provide a hard copy of the annual report containing its audited consolidated financial statements, free of charge, to its shareholders and holders of American depositary shares upon request. The Company today also announced that it has published its...

CALGARY, Alberta, April 24, 2026 (GLOBE NEWSWIRE) — Questor Technology Inc. (“Questor” or the “Company”) (TSX-V: QST) today announced that the National Research Council of Canada (“NRC”) has awarded the Company $1.9 million to complete development and launch commercialization of Questor’s 1500kW Rankine Cycle (“ORC”) Heat-to-Power Generation System. Sustainable Development Technology Canada (“SDTC”) cleantech funding is now delivered by the National Research Council of Canada (“NRC”) through its NRC IRAP program. The NRC grant arrives at a pivotal moment, as global operators face mounting pressure to abate methane emissions, retire open flares, and generate on-site power without adding carbon. Questor’s 1500kW ORC converts both high- and low-temperature waste heat into...

If approved, Itvisma (intrathecal onasemnogene abeparvovec) will be first and only gene replacement therapy for children two years and older, teens and adults with SMA in the European UnionItvisma demonstrated clinically meaningful and statistically significant improvement in motor function in Phase III STEER studyOne-time dose of Itvisma replaces SMN1 gene, with potential to reduce need for chronic SMA treatmentBasel, April 24, 2026 – Novartis today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending marketing authorization for Itvisma® (intrathecal onasemnogene abeparvovec). The opinion supports its use for the treatment of children two years and older, teens, and adults living with 5q spinal muscular atrophy (SMA) with a...

SEATTLE, April 24, 2026 (GLOBE NEWSWIRE) — Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering advanced treatments for cancers throughout the body, today announced that it will provide several corporate updates in May 2026. Webcasts of these events, unless noted as press release only, will be posted on the Company’s website at www.perspectivetherapeutics.com. Analyst Event on Perspective’s Strategy, Enabling Technology, and PipelineAdditional details are available here.Date: May 4, 2026Time: 8:30 a.m. ET First Quarter 2026 Financial Results – Press Release OnlyThe press release will be available on the newsroom section of the Company’s website at https://perspectivetherapeutics.com/newsroom/press-releases.Date: May 11, 2026Time:...

SOUTH BEND, Ind., April 24, 2026 (GLOBE NEWSWIRE) — Strawberry Fields REIT, Inc. (NYSE AMERICAN: STRW) (the “Company”) announced today that it will report its first quarter 2026 financial results before the market opens on May 8, 2026. Further, on May 8, 2026 at 12:00 p.m. Eastern Time, the Company’s management team will be holding a conference call/webcast to discuss the 2026 first quarter results and invites current and prospective investors to join. To access the conference call, please pre-register using this link. Registrants will receive confirmation with dial-in details. A live webcast of the conference call can be accessed, on a listen-only basis, using this link. A digital replay of the call will be available on our website at www.strawberryfieldsreit.com. About Strawberry Fields REIT Strawberry Fields REIT, Inc., is a...

BEIJING, April 24, 2026 (GLOBE NEWSWIRE) — BingEx Limited (the “Company”) (Nasdaq: FLX), a leading on-demand dedicated courier service provider in China (branded as “FlashEx”), today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the Securities and Exchange Commission (“SEC”) on April 24, 2026, U.S. Eastern Time. The annual report in electronic format can be accessed on the Company’s investor relations website at http://ir.ishansong.com as well as on the SEC’s website. The Company will provide a hard copy of its annual report, containing audited consolidated financial statements, free of charge, to its shareholders and ADS holders upon request. Requests should be directed to the Investor Relations Department, BingEx Limited, Building 6, Zhongguancun Dongsheng International...

BEIJING, April 24, 2026 (GLOBE NEWSWIRE) — KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HK: 2076) today announced the continued execution of its share repurchase program, utilizing over RMB27.3 million to repurchase 597,224 ordinary shares on April 23. With this latest repurchase, the Company has deployed over RMB1 billion toward share repurchases year-to-date in 2026. This effort underscores the Company’s ongoing commitment to delivering value to shareholders. CONTACT: CONTACT: PIACENTE FINANCIAL COMMUNICATIONS kanzhun@tpg-ir.com

Zug, April 24, 2026 – Multitude AG, a listed European FinTech company, offering digital lending and online banking services to consumers, SMEs, and institutional clients, (“Multitude”, “Company” or “Group”) announces the following resolutions made by its Annual General Meeting, which took place today. RESOLUTIONS OF THE ANNUAL GENERAL MEETING Approval of the Combined Management Report, the Separate Financial Statements and the Consolidated Financial Statements for 2025, acceptance of the Auditors’ Reports The Annual General Meeting approved the Combined Management Report, the Separate Financial Statements and the Consolidated Financial Statements 2025. Resolution on the appropriation of available earningsThe total available earnings of Multitude AG in the financial year 2025 amount to EUR 71,289,106. The Annual General Meeting decided...